A critical look at the new possibilities of therapeutic use of statins – a summary of the current state of knowledge
Hypercholesterolemia is a condition characterized by total cholesterol levels exceeding 200 mg/dl. A breakthrough in its treatment was the introduction of the first representative of the status - lovastatin. The mechanism of their action relies on inhibition of the activity of 3-hydroxy-3-methylglut...
Main Authors: | Kacper Kossakowski, Klaudia Katarzyna Orzechowska, Weronika Sikora, Wiktoria Grabowska, Kornelia Kowalska, Radosław Kujawski, Kamila Czora-Poczwardowska, Michał Szulc, Przemysław Łukasz Mikołajczak, Joanna Bartkowiak-Wieczorek |
---|---|
Format: | Article |
Language: | Polish |
Published: |
Polish Pharmaceutical Society
2023-10-01
|
Series: | Farmacja Polska |
Subjects: | |
Online Access: | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2023%2F5%2F06_SZ_Statyny_n.pdf |
Similar Items
-
The impact of the nocebo effect on discontinuation of statin therapy due to myopathy in patients with cardiovascular disease – a review
by: Jakub Stanek, et al.
Published: (2024-11-01) -
Nonadherence to statins: individualized intervention strategies outside the pill box
by: Lansberg P, et al.
Published: (2018-05-01) -
Pleiotropic effects of statins
by: Narasaraju Kavalipati, et al.
Published: (2015-01-01) -
Nocebo in Biosimilars and Generics in Neurology: A Systematic Review
by: Ioanna Spanou, et al.
Published: (2019-07-01) -
Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
by: Yoichi Morofuji, et al.
Published: (2022-01-01)